Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
Top Cited Papers
- 1 September 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 378 (9796), 1079-1088
- https://doi.org/10.1016/s0140-6736(11)60780-0
Abstract
No abstract availableKeywords
Funding Information
- British Microcirculation Society
- Roche
- Les Laboratories Pierre Fabre
This publication has 39 references indexed in Scilit:
- Comparison of Platinum-Based Chemotherapy in Patients Older and Younger than 70 Years: An Analysis of Southwest Oncology Group Trials 9308 and 9509Journal of Thoracic Oncology, 2011
- Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancerAnnals of Oncology, 2009
- EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly populationAnnals of Oncology, 2009
- Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3‐weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancerCancer, 2008
- International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiencyEuropean Journal of Cancer, 2007
- Weekly Paclitaxel Combined with Monthly Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II StudyJournal of Thoracic Oncology, 2006
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsThe New England Journal of Medicine, 1999
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987